학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 246건 | 목록 1~10
Academic Journal
Long MB; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom.; Gilmour A; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom.; Kehl M; Vaccine and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.; Tabor DE; Vaccine and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.; Keller AE; Vaccine and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.; Warrener P; Vaccine and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.; Gopalakrishnan V; Vaccine and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.; Rosengren S; Translational Science and Experimental Medicine, Respiratory & Immunology, Respiratory and Immunology, and.; Crichton ML; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom.; McIntosh E; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom.; Giam YH; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom.; Keir HR; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom.; Brailsford W; Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; and.; Hughes R; Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.; Belvisi MG; Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; and.; Sellman BR; Vaccine and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.; DiGiandomenico A; Vaccine and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.; Chalmers JD; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom.
Publisher: American Thoracic Society Country of Publication: United States NLM ID: 9421642 Publication Model: Print Cited Medium: Internet ISSN: 1535-4970 (Electronic) Linking ISSN: 1073449X NLM ISO Abbreviation: Am J Respir Crit Care Med Subsets: MEDLINE
Academic Journal
Pinkerton JW; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Respiratory Pharmacology group, Airway Disease section, NHLI, Imperial College, London, UK.; Preite S; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Piras A; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Zervas D; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Respiratory Pharmacology group, Airway Disease section, NHLI, Imperial College, London, UK.; Markou T; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Respiratory Pharmacology group, Airway Disease section, NHLI, Imperial College, London, UK.; Freeman MS; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Respiratory Pharmacology group, Airway Disease section, NHLI, Imperial College, London, UK.; Hofving T; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Ivarsson E; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Bonvini SJ; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Respiratory Pharmacology group, Airway Disease section, NHLI, Imperial College, London, UK.; Brailsford W; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Yrlid L; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Belvisi MG; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Respiratory Pharmacology group, Airway Disease section, NHLI, Imperial College, London, UK.; Birrell MA; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden. mark.birrell@astrazeneca.com.; Respiratory Pharmacology group, Airway Disease section, NHLI, Imperial College, London, UK. mark.birrell@astrazeneca.com.
Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-993X (Electronic) Linking ISSN: 14659921 NLM ISO Abbreviation: Respir Res Subsets: MEDLINE
Academic Journal
van Laar JM; Division of Internal Medicine and Dermatology, Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.; Lei A; Patient Safety BioPharmaceuticals, Chief Medical Office, R&D, AstraZeneca, Barcelona, Spain.; Safy-Khan M; Division of Internal Medicine and Dermatology, Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.; Almquist J; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden.; Belfield G; Translational Genomics, Discovery Biology SE, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Edman K; Mechanistic and Structural Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Öberg L; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Angermann BR; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Dillmann I; Translational Genomics, Discovery Biology SE, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Berntsson P; Bioscience COPD/IPF, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Etal D; Translational Genomics, Discovery Biology SE, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Dainty I; Bioscience COPD/IPF, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Astbury C; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Belvisi MG; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Respiratory Pharmacology, National Heart and Lung Institute, Imperial College London, London, UK.; Nemes S; Early Biometrics and Statistical Innovation, Data Science & AI, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Platt A; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Prothon S; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden.; Samuelsson S; Clinical Development, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Svanberg P; Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Keen C; Clinical Development, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE
Academic Journal
Saunders P; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Oxford University Hospitals NHS Trust, Oxford, United Kingdom.; Wu Z; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.; Fahy WA; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.; Stewart ID; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Saini G; Centre for Respiratory Research, NIHR Biomedical Research Centre, Translational Medical Sciences, University of Nottingham, Nottingham, United Kingdom.; Smith DJF; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.; Braybrooke R; Centre for Respiratory Research, NIHR Biomedical Research Centre, Translational Medical Sciences, University of Nottingham, Nottingham, United Kingdom.; Stock C; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Renzoni EA; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.; Johnson SR; Centre for Respiratory Research, NIHR Biomedical Research Centre, Translational Medical Sciences, University of Nottingham, Nottingham, United Kingdom.; Jenkins RG; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.; Belvisi MG; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Respiratory and Immunology, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden.; Smith JA; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Division of Infection, Immunity and Respiratory Medicine, The University of Manchester, Manchester, United Kingdom.; Maher TM; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Hastings Centre for Pulmonary Research and Division of Pulmonary, Critical Care and Sleep Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.; Molyneaux PL; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
Publisher: American Thoracic Society Country of Publication: United States NLM ID: 101600811 Publication Model: Print Cited Medium: Internet ISSN: 2325-6621 (Electronic) Linking ISSN: 23256621 NLM ISO Abbreviation: Ann Am Thorac Soc Subsets: MEDLINE
Academic Journal
Hristova VA; Dynamic Omics, Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; These authors contributed equally.; Watson A; Faculty of Medicine, University of Southampton, Southampton, UK.; School of Clinical Medicine, University of Cambridge, Cambridge, UK.; These authors contributed equally.; Chaerkady R; Dynamic Omics, Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Glover MS; Dynamic Omics, Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Ackland J; Faculty of Medicine, University of Southampton, Southampton, UK.; Angerman B; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Belfield G; Translational Genomics, Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Belvisi MG; Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; NHLI, Imperial College, London, UK.; Burke H; Faculty of Medicine, University of Southampton, Southampton, UK.; NIHR Southampton Biomedical Research Centre, University Hospital, Southampton, UK.; Cellura D; Faculty of Medicine, University of Southampton, Southampton, UK.; Clark HW; Neonatology, Faculty of Population Health Sciences, EGA Institute for Women's Health, University College London, London, UK.; NIHR University College London Hospital Biomedical Research, University College London Hospital, London, UK.; Etal D; Translational Genomics, Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Freeman A; Faculty of Medicine, University of Southampton, Southampton, UK.; NIHR Southampton Biomedical Research Centre, University Hospital, Southampton, UK.; Heinson AI; Faculty of Medicine, University of Southampton, Southampton, UK.; Hess S; Dynamic Omics, Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Hühn M; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Hall E; Faculty of Medicine, University of Southampton, Southampton, UK.; Mackay A; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; NHLI, Imperial College, London, UK.; Madsen J; Faculty of Medicine, University of Southampton, Southampton, UK.; McCrae C; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, USA.; Muthas D; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Novick S; Data Sciences and Quantitative Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Ostridge K; Faculty of Medicine, University of Southampton, Southampton, UK.; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Öberg L; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Platt A; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Postle AD; Faculty of Medicine, University of Southampton, Southampton, UK.; Spalluto CM; Faculty of Medicine, University of Southampton, Southampton, UK.; Vaarala O; Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Wang J; Dynamic Omics, Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Staples KJ; Faculty of Medicine, University of Southampton, Southampton, UK.; NIHR Southampton Biomedical Research Centre, University Hospital, Southampton, UK.; Wilkinson TMA; Faculty of Medicine, University of Southampton, Southampton, UK.; NIHR Southampton Biomedical Research Centre, University Hospital, Southampton, UK.
Publisher: European Respiratory Society Country of Publication: England NLM ID: 101671641 Publication Model: eCollection Cited Medium: Print ISSN: 2312-0541 (Print) Linking ISSN: 23120541 NLM ISO Abbreviation: ERJ Open Res Subsets: PubMed not MEDLINE
Editorial & Opinion
Yoon M; Air Pollution Exposure Laboratory, Division of Respiratory Medicine, Department Medicine, Vancouver Coastal Health Research Institute, The University of British Columbia, Vancouver, BC, Canada.; Ryu MH; Air Pollution Exposure Laboratory, Division of Respiratory Medicine, Department Medicine, Vancouver Coastal Health Research Institute, The University of British Columbia, Vancouver, BC, Canada.; Huff RD; Air Pollution Exposure Laboratory, Division of Respiratory Medicine, Department Medicine, Vancouver Coastal Health Research Institute, The University of British Columbia, Vancouver, BC, Canada.; Belvisi MG; Research and Early Development, Respiratory Pharmacology Group, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Airway Disease, National Heart and Lung Institute, Imperial College London, London, UK.; Smith J; Division of Infection, Immunity, and Respiratory Medicine, University of Manchester, 16 Manchester Academic Health Sciences Centre, and Manchester University NHS Foundation 17 Trust, Manchester, UK.; Carlsten C; Air Pollution Exposure Laboratory, Division of Respiratory Medicine, Department Medicine, Vancouver Coastal Health Research Institute, The University of British Columbia, Vancouver, BC, Canada. carlsten@mail.ubc.ca.; The Lung Center, Vancouver General Hospital-Gordon and Leslie Diamond Health Care Centre, 2775 Laurel St. 7th Floor, Vancouver, BC, V5Z 1M9, Canada. carlsten@mail.ubc.ca.
Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-993X (Electronic) Linking ISSN: 14659921 NLM ISO Abbreviation: Respir Res Subsets: MEDLINE
Academic Journal
Singh D; Medicines Evaluation Unit, Manchester University NHS Foundation Trust, Manchester, UK dsingh@meu.org.uk.; Division of Infection, Immunity and Respiratory Medicine, University of Manchester and Manchester University NHS Foundation Trust, Manchester, UK.; Beier J; insaf Respiratory Research Institute Wiesbaden, Wiesbaden, Germany.; Astbury C; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Belvisi MG; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Respiratory Pharmacology Group, Airway Disease, National Heart and Lung Institute, Imperial College London, London, UK.; Da Silva CA; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Jauhiainen A; BioPharma Early Biometrics and Statistical Innovation, Data Science & AI, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Jimenez E; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Barcelona, Spain.; Lei A; Patient Safety BioPharma, Chief Medical Office, R&D, AstraZeneca, Barcelona, Spain.; Necander S; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Smith JA; Division of Infection, Immunity and Respiratory Medicine, University of Manchester and Manchester University NHS Foundation Trust, Manchester, UK.; Wählby Hamrén U; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden.; Xin W; BioPharma Early Biometrics and Statistical Innovation, Data Science & AI, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Psallidas I; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1399-3003 (Electronic) Linking ISSN: 09031936 NLM ISO Abbreviation: Eur Respir J Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Belvisi MG
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어